Tau-positron emission tomography (PET) tracing and 18F FDG (fluorodeoxyglucose)-PET studies show overlap between hypometabolism of glucose and tau deposition in the brains of FTD patients (Su et al., 2020). This evidence concerns the gene MAPT and frontotemporal dementia.